Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer
IntroductionColorectal cancer (CRC) is a leading cause of cancer-related mortality globally. Although tumor immunotherapy is widely recognized for treating unresectable CRC, challenges such as ineffective immunotherapy and drug resistance remain prevalent. While intratumor microbiome-derived butyrat...
Saved in:
Main Authors: | Linsheng Xu, Bingde Hu, Jingli He, Xin Fu, Na Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1510851/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy
by: Alexandra Laura Mederle, et al.
Published: (2025-01-01) -
The specificity of ten non-digestible carbohydrates to enhance butyrate-producing bacteria and butyrate production in vitro fermentation
by: Jingjing Xu, et al.
Published: (2023-11-01) -
Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
by: Fatima J. Kadhim, et al.
Published: (2025-01-01) -
MOX Nanosensors to Detect Colorectal Cancer Relapses from Patient’s Blood at Three Years Follow-Up, and Gender Correlation
by: Michele Astolfi, et al.
Published: (2025-01-01) -
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer
by: Jinbao Chen, et al.
Published: (2025-02-01)